917
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5
CLINICAL CHARACTERISTICS AND COURSE OF OBSTRUCTIVE BRONCHITIS
IN CHILDREN
Murtazayeva Zilola Faxriddinovna
Department of Fundamental Medical Sciences of the Asian International University.
Bukhara, Uzbekistan.
https://doi.org/10.5281/zenodo.15466212
Abstract. Obstructive bronchitis is one of the most frequently diagnosed lower
respiratory tract diseases in pediatric populations, especially in children under five years of age.
It presents with bronchial obstruction due to inflammation, mucosal edema, and
increased mucus production, often triggered by viral respiratory infections. This review article
discusses the clinical features, etiological factors, pathophysiology, diagnostic challenges,
differential diagnosis, and treatment strategies specific to pediatric patients, along with potential
complications and the long-term impact on respiratory health.
Keywords: Obstructive bronchitis, virus (RSV), chest radiography, bronchodilators,
oxygen therapy.
Introduction:
Bronchitis in children is often categorized as either acute or chronic and further classified
into obstructive and non-obstructive forms. Obstructive bronchitis in children is most commonly
acute and is distinguished by temporary but significant narrowing of the lower airways. Due to
anatomical and physiological differences in children—such as narrower bronchi, increased
airway reactivity, and underdeveloped immune responses—the presentation and progression of
the disease significantly differ from that in adults.
Etiology and Pathophysiology:
In most cases, viral infections are the primary cause of pediatric obstructive bronchitis.
The most common pathogens include:
Respiratory syncytial virus (RSV)
Rhinovirus
Influenza and parainfluenza viruses
Adenovirus
Human metapneumovirus
The pathogenesis involves:
Bronchial inflammation
Mucosal edema
Hypersecretion of mucus
Bronchospasm and airway hyperresponsiveness
These changes result in partial airway obstruction, particularly during expiration, leading
to air trapping, hyperinflation, and impaired gas exchange.
Clinical Manifestations:
Early Signs and Symptoms:
Dry, hacking cough that becomes productive over time
Nasal congestion and rhinorrhea
Low-grade fever (occasionally high in viral etiologies)
Obstructive Signs:
Wheezing (often bilateral and diffuse)
918
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5
Prolonged expiration
Tachypnea and dyspnea
Retractions of the intercostal and subcostal spaces
Use of accessory muscles during breathing
Chest tightness and discomfort
Infants may present with:
Feeding difficulties
Lethargy or irritability
Cyanosis in severe cases
Diagnostic Approach:
Diagnosis is typically clinical. Key tools include:
Physical examination: Wheezing, rhonchi, prolonged expiratory phase
Pulse oximetry: To assess oxygen saturation
Chest radiography (if necessary): May show hyperinflation, flattened diaphragm, and
increased bronchovascular markings
Laboratory tests are not routinely required unless:
Bacterial superinfection is suspected
Differential diagnosis is unclear
Differential Diagnosis:
Bronchial asthma
Foreign div aspiration
Pneumonia
Cystic fibrosis
Congenital airway malformations
Pertussis
A thorough patient history, including family atopy, recurrent infections, or exposure to
tobacco smoke, helps distinguish obstructive bronchitis from chronic or recurrent conditions.
Management Strategies:
Most cases of obstructive bronchitis in children are self-limited and require supportive
treatment. However, management should be individualized based on the severity of symptoms.
Supportive Care:
Adequate fluid intake
Antipyretics for fever
Saline nasal drops and gentle suctioning for infants
Pharmacological Interventions:
Bronchodilators (e.g., inhaled salbutamol) — may reduce wheezing in some children
Inhaled corticosteroids — generally not recommended for acute episodes but may be
considered in recurrent cases or if asthma is suspected
Antibiotics — only indicated if there is clear evidence of bacterial infection
Oxygen therapy — for children with hypoxia or severe respiratory distress
Course of the Illness and Prognosis:
In most children, symptoms resolve within 7 to 10 days, though the cough may persist for
up to three weeks. Recurrence is possible, especially in children with:
Atopic background
Family history of asthma
919
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5
Prematurity or neonatal respiratory complications
Environmental factors (e.g., exposure to tobacco smoke, air pollution)
Repeated episodes of obstructive bronchitis, particularly those associated with wheezing,
may be an early sign of pediatric asthma.
Prevention and Long-Term Outlook:
Preventive strategies include:
Promoting breastfeeding
Reducing exposure to environmental tobacco smoke
Ensuring timely immunization (especially against influenza and RSV)
Avoiding overcrowded environments during respiratory virus seasons
Long-term prognosis is generally excellent. However, a small subset of children may
develop chronic respiratory issues or progress to asthma, necessitating regular follow-up and
pulmonary function monitoring.
Conclusion:
Obstructive bronchitis in children is a prevalent respiratory condition with a generally
favorable prognosis. Its clinical presentation is influenced by age-related anatomical and
physiological factors. Early recognition, differentiation from other causes of wheezing, and
appropriate symptomatic management are critical to reducing morbidity and preventing
complications. Further research into predictive markers for asthma development following
recurrent obstructive bronchitis episodes may enhance long-term care strategies.
REFERENCES
1.
Saodat, A., Vohid, A., Ravshan, N., & Shamshod, A. (2020). MRI study in patients with
idiopathic cokearthrosis of the hip joint.
International Journal of Psychosocial
Rehabilitation
,
24
(2), 410-415.
2.
Axmedov, S. J. (2023). EFFECTS OF THE DRUG MILDRONATE.
Innovative
Development in Educational Activities
,
2
(20), 40-59.
3.
Jamshidovich, A. S. (2023). ASCORBIC ACID: ITS ROLE IN IMMUNE SYSTEM,
CHRONIC INFLAMMATION DISEASES AND ON THE ANTIOXIDANT
EFFECTS.
EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE
,
3
(11),
57-60.
4.
Jamshidovich, A. S. (2023). THE ROLE OF THIOTRIAZOLINE IN THE
ORGANISM.
Ta'lim innovatsiyasi va integratsiyasi
,
9
(5), 152-155.
5.
Jamshidovich,
A.
S.
(2023).
HEPTRAL
IS
USED
IN
LIVER
DISEASES.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
35
(3),
76-78.
6.
Jamshidovich, A. S. (2023).
EFFECT OF TIVORTIN ON CARDIOMYOCYTE CELLS AND
ITS ROLE IN MYOCARDIAL INFARCTION
.
Gospodarka i Innowacje.
,
42
, 255-257.
7.
Jamshidovich,
A.
S.
(2024).
NEUROPROTECTIVE
EFFECT
OF
CITICOLINE.
EUROPEAN
JOURNAL
OF
MODERN
MEDICINE
AND
PRACTICE
,
4
(1), 1-4.
8.
Jamshidovich, A. S. (2024). THE ROLE OF TRIMETAZIDINE IN ISCHEMIC
CARDIOMYOPATHY.
Journal of new century innovations
,
44
(2), 3-8.
9.
Jamshidovich,
A.
S.
(2024).
ВСЕ
ЭФФЕКТЫ
ПРЕПАРАТА
ИМУДОН.
TADQIQOTLAR
,
31
(2), 39-43.
920
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5
10.
Jamshidovich, A. S. (2024). SPECIFIC FEATURES OF THE EFFECT OF THE
HEPARIN DRUG.
TADQIQOTLAR
,
31
(2), 34-38.
11.
Jamshidovich, A. S. (2024). USE OF GLUCOCORTICOSTEROIDS IN PEDIATRIC
PRACTICE.
TADQIQOTLAR
,
31
(2), 29-33.
12.
Jamshidovich,
A.
S.
(2024).
РОЛЬ
ИНТЕЛЛАНОВОГО
СИРОПА
И
ЦИАНОКОБАЛАМИНА В УЛУЧШЕНИИ ПАМЯТИ.
TADQIQOTLAR
,
31
(2), 44-48.
13.
Jamshidovich, A. S. (2024). TREATMENT OF POLYNEUROPATHY WITH
BERLITHION.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 201-209.
14.
Jamshidovich,
A.
S.
(2024).
USE
OF
ASCORIL
IN
BRONCHIAL
ASTHMA.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 191-200.
15.
Jamshidovich,
A.
S.
(2024).
THE
IMPORTANCE
OF
THE
DRUG
ARTOXAN.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 182-190.
16.
Jamshidovich, A. S. (2024). THE ROLE OF RENGALIN IN CHRONIC
BRONCHITIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 116-123.
17.
Jamshidovich, A. S. (2024).
THE ROLE OF ALMAGEL DRUG IN GASTRIC AND
DUODENAL WOUND DISEASE.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 173-181.
18.
Jamshidovich, A. S. (2024). THE ROLE OF CODELAK BRONCHO SYRUP IN
CHILDREN'S PRACTICE.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ
В МИРЕ
,
38
(4), 109-115.
19.
Jamshidovich, A. S. (2024). THE AEVIT DRUG EFFECT.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(4), 124-132.
20.
Jamshidovich, A. S. (2024). THE IMPORTANCE OF ALCHEBA DRUG IN POST-
STROKE APHASIA.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 132-138.
21.
Jamshidovich, A. S. (2024). THE ROLE OF HYALURON CHONDRO DRUG IN
OSTEOARTHROSIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 139-145.
22.
Jamshidovich,
A.
S.
(2024).
EFFECT
OF
SIMETHICONE
DROP
IN
FLATULENCE.
Лучшие интеллектуальные исследования
,
14
(1), 95-101.
23.
Jamshidovich, A. S. (2024). BENEFITS OF BETADINE SOLUTION.
Лучшие
интеллектуальные исследования
,
14
(1), 116-122.
24.
Jamshidovich, A. S. (2024). EFFECT INHALED GLUCOCORTICOIDS IN CHRONIC
OBSTRUCTIVE
PULMONARY
DISEASE
AND
BRONCHIAL
ASTHMA.
TADQIQOTLAR
,
31
(1), 171-180.
25.
Jamshidovich, A. S. (2024). USE OF VIGANTOL IN RICKETS.
Лучшие
интеллектуальные исследования
,
14
(1), 102-108.
26.
Jamshidovich, A. S. (2024). THE VITAPROST DRUG RESULTS.
Лучшие
интеллектуальные исследования
,
14
(1), 109-115.
27.
Jamshidovich, A. S. (2024). THE ROLE OF BISEPTOL DRUG IN URINARY TRACT
DISEASE.
Лучшие интеллектуальные исследования
,
14
(1), 89-94.
28.
Jamshidovich,
A.
S.
(2024).
PROPERTIES
OF
THE
DRUG
DORMIKIND.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(5), 88-92.
921
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5
29.
Jamshidovich, A. S., & Komilovich, E. B. (2024). IMMUNOMODULATORY
FUNCTION OF DIBAZOL DRUG.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ
ИДЕИ В МИРЕ
,
38
(5), 83-87.
30.
Jamshidovich, A. S., & Komilovich, E. B. (2024). ADVANTAGES OF THE DRUG
HEPTRAL.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(5),
98-101.
31.
Эргашов, Б. К., & Ахмедов, Ш. Ж. (2024). ГИПЕРТОНИЧЕСКАЯ БОЛЕЗНЬ
ЭТИОЛОГИЯ.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 59-69.
32.
Komilovich,
E.
B.,
&
Jamshidovich,
A.
S.
(2024).
HYPERTENSION,
CLASSIFICATION
AND
PATHOGENESIS.
ОБРАЗОВАНИЕ
НАУКА
И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 50-58.
33.
Komilovich, E. B., & Jamshidovich, A. S. (2024). YURAK ISHEMIYASI.
STENOKARDIYADA SHOSHILINCH TIBBIY YORDAM.
ОБРАЗОВАНИЕ НАУКА
И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 12-20.
34.
Komilovich,
E.
B.,
&
Jamshidovich,
A.
S.
(2024).
HYPERTENSION
ETIOLOGY.
ОБРАЗОВАНИЕ
НАУКА
И
ИННОВАЦИОННЫЕ
ИДЕИ
В
МИРЕ
,
38
(6), 32-41.
35.
Komilovich, E. B., & Jamshidovich, A. S. (2024). CARDIAC ISCHEMIA. ANGINA
NURSING DIAGNOSIS AND CARE.
Journal of new century innovations
,
46
(1), 44-52.
36.
Jamshidovich, A. S. (2024). IMPORTANT INDICATIONS OF THE DRUG
WOBENZYM.
Journal of new century innovations
,
46
(1), 29-32.
37.
Jamshidovich, A. S. (2024). THE RESULTS OF THE EFFECT OF THE DRUG
VALIDOL.
Journal of new century innovations
,
46
(1), 19-23.
38.
Jamshidovich, A. S. (2024). VIFERON USE IN CHILDREN.
Journal of new century
innovations
,
46
(1), 24-28.
39.
Jamshidovich,
A.
S.
(2024).
USE
OF
DUSPATALIN
(MEBEVERINE
HYDROCHLORIDE)
IN
GASTROINTESTINAL
DISEASES.
ОБРАЗОВАНИЕ
НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(5), 93-97.
40.
Jamshidovich, A. S. (2024). ЭФФЕКТЫ СИРОПА ДЕПАКИНА (ВАЛЬПРОЕВАЯ
КИСЛОТА).
Ta'lim innovatsiyasi va integratsiyasi
,
14
(2), 148-152.
41.
Jamshidovich, A. S., & Komilovich, E. B. (2024). THE IMPORTANCE OF THE DRUG
ALLOCHOL
FOR
CHRONIC
CHOLECYSTITIS.
Ta'lim
innovatsiyasi
va
integratsiyasi
,
14
(2), 133-137.
42.
Jamshidovich, A. S., & Komilovich, E. B. (2024). ВАЖНЫЕ СВОЙСТВА
ПРЕПАРАТА
ДЕ-НОЛ
(субцитрат
висмута).
Ta'lim
innovatsiyasi
va
integratsiyasi
,
14
(2), 143-147.
43.
Jamshidovich, A. S., & Komilovich, E. B. (2024). SPECIAL FEATURES OF
BUDECTON DRUG.
Ta'lim innovatsiyasi va integratsiyasi
,
14
(2), 138-142.
44.
Jamshidovich, A. S. (2024). ЭФФЕКТИВНОЕ ВОЗДЕЙСТВИЕ ПРЕПАРАТА
КЕЙВЕР.
Ta'lim innovatsiyasi va integratsiyasi
,
15
(3), 137-143.
45.
Jamshidovich,
A.
S.
(2024).
USEFUL
PROPERTIES
OF
THE
DRUG
YODOFOL.
Ta'lim innovatsiyasi va integratsiyasi
,
15
(3), 144-149.
46.
Jamshidovich, A. S. (2024). FITOTERAPIYANING AKUSHER-GINEKOLOGIYADA
AHAMIYATI.
Лучшие интеллектуальные исследования
,
15
(2), 121-125.
922
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5
47.
Jamshidovich,
A.
S.
(2024).
THE
IMPORTANCE
OF
THE
DRUG
DOPROKIN.
Лучшие интеллектуальные исследования
,
15
(2), 109-114.
48.
Jamshidovich, A. S. (2024). THE EFFECT OF DOSTINEX ON THE BODY.
Лучшие
интеллектуальные исследования
,
15
(2), 115-120.
49.
Jamshidovich,
A. S. (2024). РЕЗУЛЬТАТЫ ЭФФЕКТИВНОГО ДЕЙСТВИЯ ПРЕПАРАТА
КАНЕФРОН
.
Лучшие интеллектуальные исследования
,
15
(2), 138-143.
50.
Jamshidovich,
A.
S.
(2024). СОВРЕМЕННЫЕ ЭФФЕКТЫ ПРЕПАРАТА
ИНДОЛ.
Лучшие интеллектуальные исследования
,
15
(2), 126-131.
51.
Jamshidovich, A. S. (2024). EFFECT OF ISMIZHEN DRUG ON BODY
IMMUNITY.
Лучшие интеллектуальные исследования
,
15
(2), 132-137.
52.
Jamshidovich, A. S. (2024). POSITIVE EFFECTS OF THE DRUG CARCIL.
Ta'lim
innovatsiyasi va integratsiyasi
,
15
(3), 127-131.
53.
Jamshidovich, A. S. (2024). PЕЗУЛЬТАТЫ ЭФФЕКТИВНОГО ДЕЙСТВИЯ
KАВИНТОНА.
Ta'lim innovatsiyasi va integratsiyasi
,
15
(3), 132-136.
54.
Jamshidovich, A. S. (2024). Современный Эффект Спрея Мометазон.
Research
Journal of Trauma and Disability Studies
,
3
(3), 62-65.
55.
Jamshidovich, A. S. (2024). THE ROLE OF" SIMONTE PLUS" DRUG IN THE
MODERN TREATMENT OF BRONCHIAL ASTHMA.
EUROPEAN JOURNAL OF
MODERN MEDICINE AND PRACTICE
,
4
(5), 66-70.
56.
Jamshidovich, A. S. (2024). FEATURES OF THE BIOMECHANISM OF THE DRUG
LEVOMYCETIN (CHLORAMPHENICOL).
EUROPEAN JOURNAL OF MODERN
MEDICINE AND PRACTICE
,
4
(9), 298-301.
57.
Jamshidovich, A. S. (2024). THE MOST IMPORTANT INDICATORS OF OMEGA 3
SUBSTANCE IN THE METABOLISM OF THE HUMAN BODY.
EUROPEAN
JOURNAL OF MODERN MEDICINE AND PRACTICE
,
4
(10), 113-117.
58.
Komilovich, E. B., & Khalimovich,
M. N. (2024). CARDIAC ISCHEMIA. ANGINA
CLINICAL FORMS AND DIAGNOSIS
.
Journal of new century innovations
,
46
(1), 70-78.
59.
Komilovich, E. B. (2024). CORONARY HEART DISEASE. ANGINA EMERGENCY
CARE.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(7),
235-242.
60.
Komilovich, E. B. (2024). YURAK ISHEMIK KASALLIGI. STENOKARDIYANI
DAVOLASHNING ZAMONAVIY TAMOYILLARI.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 3-11.
61.
Jamshidovich, A. S. (2024). THE MOST IMPORTANT BENEFITS OF GINGER FOR
THE HUMAN BODY'S IMMUNITY.
EUROPEAN JOURNAL OF MODERN
MEDICINE AND PRACTICE
,
4
(11), 269-273.
62.
Axmedov, S. (2024). THE SPECIFIC EFFECT OF THE DRUG" BAKLASAN" IN
CEREBROVASCULAR DISEASES AND ITS PRACTICAL SIGNIFICANCE
TODAY.
Modern Science and Research
,
3
(12), 485-492.
63.
Komilovich, E. B. Z. (2023). Coronary Artery Disease.
EUROPEAN JOURNAL OF
MODERN MEDICINE AND PRACTICE
,
3
(12), 81-87.
64.
Komilovich,
E.
B.
(2024).
CORONARY
HEART
DISEASE.
ANGINA
TREATMENT.
Journal of new century innovations
,
46
(1), 95-104.
65.
Komilovich, E. B. (2024). HYPERTENSION TREATMENT.
ОБРАЗОВАНИЕ НАУКА
И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(7), 227-234.
923
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 5
66.
Эргашов, Б. К. (2024). ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА. СТЕНОКАРДИЯ
ПРОФИЛАКТИКА.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 21-31.
67.
Axmedov, S. (2025). ВАЖНЫЕ СВОЙСТВА ПРЕПАРАТА ЭСКУЗАН ПРИ
СОСУДИСТЫХ ЗАБОЛЕВАНИЯХ.
Modern Science and Research
,
4
(1), 380-387.
68.
Эргашов,
Б.
К.
(2024).
ГИПЕРТОНИЧЕСКАЯ
БОЛЕЗНЬ
ДИАГНОСТИКА.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 70-78.
69.
Komilovich, E. B. (2024). HYPERTENSION DIAGNOSTICS.
ОБРАЗОВАНИЕ
НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 42-49.
70.
Xusenovich, M. S., & Turаpjаnovnа, Z. M. (2024). SEMIZLIKNING TURLI
FENOTIPLARDA
KARDIOMETABOLIK
XAVF
OMILLARINI
TAQQOSLASH.
SO‘NGI ILMIY TADQIQOTLAR NAZARIYASI
,
7
(4), 112-116.
71.
Husenovich, M. S., & Turabdjanovna, Z. M. (2024). STUDY OF DIURNAL PROFILE
OF
ARTERIAL
HYPERTENSION
IN
DIFFERENT
PHENOTYPE
OBESITY.
образование наука и инновационные идеи в мире
,
43
(1), 129-131.
72.
Xusenovich, M. S. (2024, September).
SEMIZLIKNI TURLI FENOTIPLARIDA YURAK
QON-TOMIR
KASALLIKLARINI
KELIB
CHIQISH
XAVFI
PROGNOZI.
In
INTERNATIONAL SCIENTIFIC RESEARCH CONFERENCE
(Vol. 3, No. 26, pp. 15-18).
73.
Xusenovich, M. S. (2024). O ‘ZBEKISTONDA RESPUBLIKASIDA YURAK-QON
TOMIR
KASALLIKLARI
TARQALISHI
VA
HOZIRGI
KUNDAGI
KO’RILAYOTGAN CHORA TADBIRLAR.
AMERICAN JOURNAL OF SOCIAL
SCIENCE
,
2
(3), 79-82.
74.
Xusenovich, M. S., & Allayarovich, A. A. (2024). O ‘ZBEKISTONDA YURAK-QON
TOMIR
KASALLIKLARI
TARQALISHI
VA
HOZIRGI
KUNDAGI
TENDENSIYASI.
MODELS AND METHODS FOR INCREASING THE EFFICIENCY
OF INNOVATIVE RESEARCH
,
4
(38), 54-57.
75.
Ravshanovna, X. L. (2021, June). MINIMALLY INVASIVE METHODS OF
TREATMENT OF DENTAL CARIES IN ADULTS. In
" ONLINE-CONFERENCES"
PLATFORM
(pp. 118-119).
76.
Axmedov, S. (2025). SPECIFIC PROPERTIES OF ROXERA DRUG IN
CARDIOVASCULAR DISEASES.
Modern Science and Research
,
4
(2), 472-479.
77.
Axmedov, S. (2025). THE DRUG PHYSIOTENS, THE FEATURES OF THE DRUG
AND ITS USE IN THE FIELD OF CARDIOLOGY, IN PATIENTS WITH HEAVY
BODY WEIGHT.
Modern Science and Research
,
4
(3), 350-358.
78.
Axmedov, S. (2025). THE USE OF MIRENA IN GYNECOLOGIC DISEASES AND
ITS SIGNIFICANCE.
Modern Science and Research
,
4
(4), 304-312.
79.
Axmedov, S. (2025). THE ROLE, FUNCTIONS AND IMPORTANCE OF
GLUTAMIC ACID IN THE HUMAN BODY.
Modern Science and Research
,
4
(5).
